CAViTreat
CAViTreat provides a micro-scale hydrodynamic cavitation pretreatment technology that enhances aerobic and anaerobic digestion in wastewater treatment plants. The approach degrades active pharmaceutical ingredients and reduces operational expenditures, making biological treatment more efficient. The technology was validated through collaboration with IVL Swedish Environmental Research Institute and won The Water Council's Tech Challenge 2021.
- Clean Technology
- Chemical Technology
- Hardware
- Energy
- Industrial Automation
- New Materials
- Utilities
Funding
Raised to date
$10KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 1 round
$10K · Grant
Announced Jan 2021
Disclosed cumulative: $10K
Founders
Founder details are not available yet.
Product
Problem
Conventional aerobic and anaerobic digestion processes in wastewater treatment plants often suffer from high operational expenditures (OPEX) and incomplete removal of active pharmaceutical ingredients (APIs) and other micropollutants. These inefficiencies increase costs for treatment facilities and pose environmental and public health risks when contaminants are discharged into water systems.
Solution
CAViTreat provides a micro-scale hydrodynamic cavitation pretreatment approach that enhances the efficiency of aerobic and anaerobic digestion processes. The technology applies controlled cavitation to break down complex organic matter and degrade active pharmaceutical ingredients, making subsequent biological treatment steps more effective and cost-efficient. By integrating this pretreatment step, wastewater treatment plants can achieve better pollutant removal while reducing energy consumption and operational costs. The company collaborates with research institutions such as IVL Swedish Environmental Research Institute to validate and refine its technology for real-world applications, targeting elimination of high OPEX in digestion systems.
Target Audience
Primary customers are municipal and industrial wastewater treatment facilities seeking to reduce operational costs and meet stricter environmental regulations for micropollutant removal, including operations in Europe and North America.
Features
- Micro-scale hydrodynamic cavitation technology for enhanced digestion pretreatment
- Targeted removal of active pharmaceutical ingredients from wastewater streams
- Reduces operational expenditures in aerobic and anaerobic digestion processes
- Scalable approach applicable to existing wastewater treatment infrastructure
- Validated through collaboration with IVL Swedish Environmental Research Institute on API removal
- Winner of The Water Council's Tech Challenge 2021 for elimination of high OPEX